TAIPEI, Oct. 23, 2025 /PRNewswire/ -- AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track Designation for AJ201, the first-in-class for therapy for spinal and bulbar muscular atrophy (SBMA, also known as...
Hence then, the article about fda grants fast track designation for aj201 a first in class therapy for kenndy s disease was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease )
Also on site :
- Driscoll touts Ukraine's military innovation in first public appearance since resigning as Army Secretary
- Black Lake founder Yuxiang Zhou pitted an AI agent against his top sales coach. His most experienced salespeople chose the AI
- ‘Animal Hospital’ Leads Roblox Innovation Awards 2026 Winners as Roblox Unveils 20th Anniversary Event